Capricor Therapeutics (CAPR) Misses Q3 EPS by 2c

Capricor Therapeutics (NASDAQ: CAPR) reported Q3 EPS of ($0.29), $0.02 worse than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.

You May Also Be Interested In

• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• AutoZone beats profit view but misses on revenue
• Cal-Maine Foods (CALM) PT Lowered to $80 at Stephens